Apyx Medical CorporationAPYXNASDAQ
Loading
Year-over-year SG&A expense growth
| Period | Value |
|---|---|
| Q4 2025 | 32.61% |
| Q3 2025 | -5.72% |
| Q2 2025 | 11.64% |
| Q1 2025 | -27.38% |
| Q4 2024 | 15.33% |
| Q3 2024 | 36.24% |
| Q2 2024 | -37.91% |
| Q1 2024 | 30.00% |
| Q4 2023 | -23.34% |
| Q3 2023 | -5.43% |
| Q2 2023 | -0.54% |
| Q1 2023 | -7.79% |
| Q4 2022 | 23.30% |
| Q3 2022 | -11.35% |
| Q2 2022 | -8.60% |
| Q1 2022 | 0.28% |
| Q4 2021 | 18.87% |
| Q3 2021 | 3.39% |
| Q2 2021 | 10.57% |
| Q1 2021 | 7.40% |
| Q4 2020 | 9.78% |
| Q3 2020 | 10.47% |
| Q2 2020 | -23.27% |
| Q1 2020 | -13.01% |
| Q4 2019 | 24.36% |
| Q3 2019 | 9.06% |
| Q2 2019 | -0.79% |
| Q1 2019 | 10.32% |
| Q4 2018 | 56.34% |
| Q3 2018 | -17.88% |
| Q2 2018 | 8.24% |
| Q1 2018 | 5.36% |
| Q4 2017 | -1.86% |
| Q3 2017 | -9.45% |
| Q2 2017 | 7.58% |
| Q1 2017 | 1.08% |
| Q4 2016 | 12.39% |
| Q3 2016 | 0.15% |
| Q2 2016 | -0.65% |
| Q1 2016 | 9.57% |